Shanghai Pharmaceuticals Holding Co., Ltd
SHPMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $45,060,407 | $38,540,840 | $39,010,353 | $34,301,148 |
| - Cash | $35,744,328 | $30,517,706 | $27,401,396 | $22,390,386 |
| + Debt | $47,791,733 | $42,896,731 | $38,561,432 | $31,688,642 |
| Enterprise Value | $57,107,812 | $50,919,864 | $50,170,389 | $43,599,404 |
| Revenue | $275,250,935 | $260,295,089 | $231,981,300 | $215,824,259 |
| % Growth | 5.7% | 12.2% | 7.5% | – |
| Gross Profit | $30,631,674 | $31,328,142 | $30,486,377 | $28,543,110 |
| % Margin | 11.1% | 12% | 13.1% | 13.2% |
| EBITDA | $12,064,708 | $10,904,982 | $12,421,152 | $11,274,561 |
| % Margin | 4.4% | 4.2% | 5.4% | 5.2% |
| Net Income | $4,552,528 | $3,768,000 | $5,617,152 | $5,093,467 |
| % Margin | 1.7% | 1.4% | 2.4% | 2.4% |
| EPS Diluted | 6.15 | 5.1 | 8.05 | 8.95 |
| % Growth | 20.6% | -36.6% | -10.1% | – |
| Operating Cash Flow | $5,827,258 | $5,231,520 | $4,743,361 | $5,061,326 |
| Capital Expenditures | -$2,400,875 | -$2,970,610 | -$2,684,864 | -$4,118,771 |
| Free Cash Flow | $3,426,383 | $2,260,910 | $2,058,497 | $942,555 |